Xilio Therapeutics, Inc. (XLO)
8.10
-0.05
(-0.61%)
USD |
NASDAQ |
May 19, 16:00
8.10
0.00 (0.00%)
After-Hours: 16:43
Xilio Therapeutics EPS Diluted (TTM) : -3.657 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Verastem, Inc. | -2.738 |
| Opus Genetics, Inc. | -1.355 |
| Sensei Biotherapeutics, Inc. | -13.98 |
| ACADIA Pharmaceuticals, Inc. | 2.196 |
| Alnylam Pharmaceuticals, Inc. | 4.209 |